Nobel Prize winner to deliver Boyd Lecture at UGA

Boyd lecture 2012-Beutler

March 26, 2012

Print
Writer:
James Hataway

James Hataway

Public Relations Coordinator

Recent and archived articles by James Hataway


Division of Marketing & Communications
Work: 706-542-6927
Email:

Contact:
David Lee

David Lee

VP for Research

Office of VP for Research
Research, Office of

Photography

  • magnify Boyd lecture 2012-Beutler

    Bruce Beutler is the 2011 Nobel Laureate in Physiology or Medicine and director of the Center for Genetics of Host Defense at the University of Texas Southwestern Medical Center at Dallas. He will deliver the 2012 George H. Boyd Distinguished Lecture at 4 p.m. on April 11, in room 102 of the Zell B. Miller Learning Center.

Scroll Left 1 Scroll Right

Athens, Ga. - Bruce Beutler, 2011 Nobel Laureate in Physiology or Medicine and director of the Center for Genetics of Host Defense at the University of Texas Southwestern Medical Center at Dallas, will deliver the 2012 George H. Boyd Distinguished Lecture. He will speak at 4 p.m. on April 11, in room 102 of the Zell B. Miller Learning Center. His lecture is titled "Forward Genetic Analysis of Innate Immunity."

The Boyd Distinguished Lecture Series, supported by UGA's Office of the Vice President for Research and the William S. and Elizabeth K. Boyd Foundation, brings national leaders and policymakers to UGA in science, education and related fields to discuss applications of research to contemporary issues in education. The lectures are free and open to all.

"UGA is indeed fortunate to have the support of the Boyd Foundation. The ability to bring to UGA speakers of the highest caliber-as in the case of Dr. Beutler-enriches our campus culture and provides unique opportunities for our students to engage with some of the best minds in the world," said David Lee, UGA vice president for research.

As a postdoctoral fellow at Rockefeller University, Beutler isolated mouse tumor necrosis factor, and was the first to recognize TNF as the molecule responsible for initiating inflammation in autoimmune diseases such as rheumatoid arthritis, Crohn's disease and psoriasis. Working as an investigator for the Howard Hughes Medical Institute from 1986-2000, Beutler designed recombinant inhibitors of TNF that found wide use in the treatment of inflammatory diseases.

Moving to the Scripps Research Institute in 2000, he deciphered how a class of proteins, called Toll-like receptors, activate critical signaling pathways related to innate immunity, the first step in the body's immune response. He won the Nobel Prize for his work related to TLRs.

Beutler has authored or co-authored more than 400 publications, which have been cited more than 46,000 times. Before he received the Nobel Prize, his work was recognized by the Shaw Prize (2011), the Albany Medical Center Prize in Medicine and Biomedical Research (2009), election to the National Academy of Sciences and Institute of Medicine (2008), the Frederik B. Bang Award (2008), the Balzan Prize (2007), the Gran Prix Charles-Leopold-Mayer (2006), the William B. Coley Award (2005), the Robert-Koch-Prize (2004), and other honors.

 

 

Filed under: Medical Science, Genetics, Health Sciences

Media Relations

Executive Director for Media Communications
Greg Trevor

706 / 542-8025
Executive Editor for Media Relations
David Bill

706 / 542-9150
Media Relations Coordinator
Sara Freeland

706 / 542-8077
Media Relations Coordinator for Broadcast
Melissa Jackson

706 / 542-8089

Open Records

Open Records Manager
Bob Taylor

706 / 542-8095